Tocilizumab, atezolizumab, and stereotactic radiotherapy in recurrent glioblastoma: primary analysis of safety and efficacy of a phase 2 trial, NRG Oncology-BN010 - International Journal of Radiation Oncology, Biology, Physics www.redjournal.org/article/S0360-30…